Louise Fullwood
Legal Director
Louise advises on the protection, management and exploitation of intellectual property rights for a range of clients - from government departments to global businesses.
Louise's experience
-
Advised The European Urological Foundation, a medical research organisation, on contracts and regulatory matters related to EU-funded research consortia in the field of prostate cancer.
- United Kingdom
- Technology, Science & Industry
-
Advised Quality by Randomization Limited trading as Protas, a clinical research organisation, on contract negotiation for a novel format clinical trial carried out on behalf of Regeneron Pharmaceuticals, Inc.
- United Kingdom
- Technology, Science & Industry
-
Advised University of the Arts London, a leading educational institution, on the regulatory aspects of developing a skincare product formula for a US company. This included reviewing the current UK cosmetics regulation, particularly any changes post-Brexit compared to the EU Cosmetics Regulation.
- United Kingdom
-
Advice Blast Theory Limited on regulatory aspects of projects involving AI and live animals.
- United Kingdom
- Universities & Education
-
Advised Aston University on its wholesale review and refresh of its entire suite of template legal documents which consists of over 50 contracts, including IPR development, healthcare and international academic collaboration.
- United Kingdom
- Universities & Education
-
Advising on a global Distribution Agreement for Porton Biopharma's life saving treatment for childhood leukaemia.
- United Kingdom
- Technology, Science & Industry
-
Advising Huel on a range of commercial contracts and supply agreements as well as regulatory issues relating to its products.
- United Kingdom
- Commercial
-
Advised the Royal Commission for Al Ula on Intellectual Property Regulations. This included examining the current IP laws of Saudi Arabia, making recommendations on changes needed to achieve IP protection in the Al-Ula region, and ultimately drafting any new legislation required.
- Saudi Arabia
- Government and public sector
-
Advised Twenty20 Capital, a London-based provider of private (non-institutional) capital on its acquisition of Virgin Care (now renamed HMRC Care) a leading independent provider of community health and care services.
- United Kingdom
- Financial Services
-
Advised the Huntsworth Group, an international healthcare and communications specialist, on all aspects of the acquisition of the Nucleus Communications Group. The Nucleus Communications Group is the largest specialist medical communications network in the world and was founded in London by Dr Stephen Cameron in 1986.
- United Kingdom
- Technology, Science & Industry
Credentials
-
1997Qualified - England and Wales
-
1995Nottingham Law School - Legal Practice Course
-
1995Joined Pinsent Masons
-
1993Nottingham Law School - Diploma in Law
-
1992Nottingham College - HNC Medical Physics
-
1992The Open University - BA (Hons) Physiology
-
1987University of Nottingham, Medical Researcher
Out-Law / Insight by Louise Fullwood
People who viewed Louise Fullwood also viewed
Show me all
Désirée Fields
Legal Director
Désirée advises on worldwide trade mark and design portfolio management, international prosecution and clearance, enforcement, exploitation and commercialisation of trade marks and designs.
Dinesh Banani
Partner
Dinesh is our Head of US Securities and has been guiding corporates and investment banks through equity and debt capital markets transactions in the UK, Europe, Middle East, Africa and Asia for the last 20 years.
David Barker
Global Sector Head for Technology, Science and Industry
David is our Sector Head for Technology, Science and Industry and leads our global offering to clients in these sectors. He is recognised as a market leader in technology and privacy litigation, having acted in some of the most complex and groundbreaking litigation in the tech space.
David Doogan
Partner
David acts for Lenders and Borrowers and specialises in the finance aspects of a wide variety of corporate transactions including corporate lending (secured and unsecured), property finance transactions (both investment and development), acquisition finance and leveraged transactions, corporate reorganisations and receivables financing transactions.